Evidence map›Paper›PMID 32415086›Full record

ArticleNature communications2020

Immune-profiling of ZIKV-infected patients identifies a distinct function of plasmacytoid dendritic cells for immune cross-regulation.

Xiaoming Sun, Stephane Hua, Ce Gao, Jane E Blackmer, Zhengyu Ouyang, Kevin Ard, Andrea Ciaranello, Sigal Yawetz, Paul E Sax, Eric S Rosenberg and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Xiaoming Sun *Ragon Institute of MGH, MIT, and Harvard, Massachusetts General Hospital, Boston, MA, USA.
Stephane Hua *Ragon Institute of MGH, MIT, and Harvard, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2244-5663
Ce GaoRagon Institute of MGH, MIT, and Harvard, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-3775-790X
Jane E BlackmerRagon Institute of MGH, MIT, and Harvard, Massachusetts General Hospital, Boston, MA, USA.
Zhengyu OuyangRagon Institute of MGH, MIT, and Harvard, Massachusetts General Hospital, Boston, MA, USA.
Kevin ArdInfectious Disease Division, Massachusetts General Hospital, Boston, MA, USA.
Andrea CiaranelloInfectious Disease Division, Massachusetts General Hospital, Boston, MA, USA.
Sigal YawetzInfectious Disease Division, Brigham and Women's Hospital, Boston, MA, USA.
Paul E SaxInfectious Disease Division, Brigham and Women's Hospital, Boston, MA, USA.
Eric S RosenbergInfectious Disease Division, Massachusetts General Hospital, Boston, MA, USA.
Mathias LichterfeldRagon Institute of MGH, MIT, and Harvard, Massachusetts General Hospital, Boston, MA, USA.
Xu G YuRagon Institute of MGH, MIT, and Harvard, Massachusetts General Hospital, Boston, MA, USA. xyu@mgh.harvard.edu.
Ragon Institute of MGH, MIT and Harvard · USBrigham and Women's Hospital · USMassachusetts General Hospital · US

Funding

Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 InfectionR01AI078799 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XU · 2008 to 2017
$4.1M
Molecular basis of myelomonocytic receptor function in HIV-1 infectionR01AI087452 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SUNDBERG, ERIC JOHN · 2010 to 2014
$2.1M
A Microengraving Technology for the Study of Latently HIV-infected Primary CellsR01AI089339 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XU · 2010 to 2013
$1.6M
Targeting HIV-1 persistence with Interferon-aR33AI116228 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XU · 2016 to 2018
$1.5M
A systems biology approach to fingerprint HIV immune defense in Elite ControllersR56HL126554 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XU · 2014 to 2014
$886k
A systems biology approach to fingerprint HIV immune defense in Elite ControllersR56AI098484 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XU · 2012 to 2012
$727k
Targeting HIV-1 persistence with Interferon-aR21AI116228 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XU · 2014 to 2015
$479k
T memory stem cell aging in HIV-1 infectionR21HL121890 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XU · 2014 to 2015
$475k
NHLBI NIH HHS R21 HL121890NHLBI NIH HHS R56 HL126554NIAID NIH HHS R01 AI078799NIAID NIH HHS R01 AI087452NIAID NIH HHS R01 AI089339NIAID NIH HHS R21 AI116228NIAID NIH HHS R33 AI116228NIAID NIH HHS R56 AI098484
6 · The paper itself

Abstract

Zika virus (ZIKV) is a mosquito-borne pathogen with increasing public health significance. To characterize immune responses to ZIKV, here we examine transcriptional signatures of CD4 T, CD8 T, B, and NK cells, monocytes, myeloid dendritic cells (mDCs), and plasmacytoid dendritic cells (pDCs) from three individuals with ZIKV infection. While gene expression patterns from most cell subsets display signs of impaired antiviral immune activity, pDCs from infected host have distinct transcriptional response associated with activation of innate immune recognition and type I interferon signaling pathways, but downregulation of key host factors known to support ZIKV replication steps; meanwhile, pDCs exhibit a unique expression pattern of gene modules that are correlated with alternative cell populations, suggesting collaborative interactions between pDCs and other immune cells, particularly B cells. Together, these results point towards a discrete but integrative function of pDCs in the human immune responses to ZIKV infection.

Indexed as

AdultAnimalsB-LymphocytesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCells, CulturedCulicidaeDendritic CellsFemaleGene Expression ProfilingHumansImmunity, InnateKiller Cells, NaturalLeukocytes, MononuclearMonocytesMyeloid Cells

Identifiers

PMID32415086
PMCPMC7229207
OpenAlexW3024471453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.